managed dsip ii equity strategy Private Deal Sourcing Guide for 2025 Navigating the Divide: Active vs.
Navigating the Divide: Active vs. Passive Strategies in Today's Equity Markets NewEdge Wealth A surprising deal from Vertex Pharmaceuticals adds to Big Pharma's acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward, but mostly for derisked Reimagining the 60 40 Portfolio with Private Equity Secondaries Smart, Capital Efficient Diversification Seeking Alpha Cross Atlantic research agenda for scalable grid architectures and distributed flexibility ScienceDirect 2026 Private equity insights and data snapshots
Pay in 4 interest-free payments of $5.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


